{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:13:14Z","timestamp":1790363594137,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["CTSA Grant Number UL1 TR002377"],"award-info":[{"award-number":["CTSA Grant Number UL1 TR002377"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32 AR56950"],"award-info":[{"award-number":["T32 AR56950"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR0691427"],"award-info":[{"award-number":["AR0691427"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR04775"],"award-info":[{"award-number":["AR04775"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM08685"],"award-info":[{"award-number":["T32 GM08685"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40744-020-00248-x","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T10:03:17Z","timestamp":1605002597000},"page":"993-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effects of Therapies on Cardiovascular Events in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1034-1530","authenticated-orcid":false,"given":"Paras","family":"Karmacharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Shahukhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delamo","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikesh","family":"Chakradhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"issue":"3","key":"248_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.berh.2019.01.002","volume":"32","author":"JW Liew","year":"2018","unstructured":"Liew JW, Ramiro S, Gensler LS. Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis. Best Pract Res Clin Rheumatol. 2018;32(3):369\u201389.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"248_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/acr.20364","volume":"63","author":"S Mathieu","year":"2011","unstructured":"Mathieu S, Gossec L, Dougados M, Soubrier M. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res. 2011;63(4):557\u201363.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"248_CR3","first-page":"673","volume":"26","author":"L L\u00e9vy","year":"2008","unstructured":"L\u00e9vy L, Fautrel B, Barnetche T, Schaeverbeke T. Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol. 2008;26(4):673\u20139.","journal-title":"Clin Exp Rheumatol."},{"issue":"3","key":"248_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/ard.52.3.174","volume":"52","author":"K Lehtinen","year":"1993","unstructured":"Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis. 1993;52(3):174\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"248_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis. 2011;70(11):1921\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"248_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M14-2470","volume":"163","author":"NN Haroon","year":"2015","unstructured":"Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med. 2015;163(6):409\u201316.","journal-title":"Ann Intern Med"},{"issue":"11","key":"248_CR7","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00296-010-1416-3","volume":"30","author":"VF Azevedo","year":"2010","unstructured":"Azevedo VF, Pecoits-Filho R. Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis. Rheumatol Int. 2010;30(11):1411\u20136.","journal-title":"Rheumatol Int"},{"issue":"7","key":"248_CR8","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s10067-018-4086-2","volume":"37","author":"JA Walsh","year":"2018","unstructured":"Walsh JA, Song X, Kim G, Park Y. Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set. Clin Rheumatol. 2018;37(7):1869\u201378.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"248_CR9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(3):480\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"248_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1517\/14740338.2014.907792","volume":"13","author":"F Salvo","year":"2014","unstructured":"Salvo F, Antoniazzi S, Duong M, Molimard M, Bazin F, Fourrier-R\u00e9glat A, et al. Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies. Expert Opin Drug Saf. 2014;13(5):573\u201385.","journal-title":"Expert Opin Drug Saf"},{"issue":"26","key":"248_CR11","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen SE, Yeomans ND, Solomon DH, L\u00fcscher TF, Libby P, Husni ME, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519\u201329.","journal-title":"N Engl J Med."},{"issue":"9894","key":"248_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Coxib and traditional NSAID Trialists\u2019 (CNT) Collaboration, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet Lond Engl. 2013;382(9894):769\u201379.","journal-title":"Lancet Lond Engl."},{"issue":"11","key":"248_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa050405","volume":"352","author":"SD Solomon","year":"2005","unstructured":"Solomon SD, McMurray JJV, Pfeffer MA, Wittes J, Fowler R, Finn P, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005;352(11):1071\u201380.","journal-title":"N Engl J Med"},{"key":"248_CR14","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/acr.24025","volume":"10","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol Hoboken. 2019;10:1285\u201399.","journal-title":"Arthritis Rheumatol Hoboken"},{"issue":"8","key":"248_CR15","first-page":"1137","volume":"77","author":"M Dubreuil","year":"2018","unstructured":"Dubreuil M, Louie-Gao Q, Peloquin CE, Choi HK, Zhang Y, Neogi T. Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis. Ann Rheum Dis. 2018;77(8):1137\u201342.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"248_CR16","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.24492","volume":"60","author":"IC van Eijk","year":"2009","unstructured":"van Eijk IC, de Vries MK, Levels JHM, Peters MJL, Huizer EE, Dijkmans BC, et al. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis. Arthritis Rheum. 2009;60(5):1324\u201330.","journal-title":"Arthritis Rheum."},{"issue":"27","key":"248_CR17","doi-asserted-by":"publisher","first-page":"e11250","DOI":"10.1097\/MD.0000000000011250","volume":"97","author":"EM Zardi","year":"2018","unstructured":"Zardi EM, Pipita ME, Giorgi C, Lichinchi D, Zardi DM, Afeltra A. Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-\u03b1 antagonists and healthy matched controls. Medicine (Baltimore). 2018;97(27):e11250.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"248_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13075-017-1439-1","volume":"19","author":"G Deyab","year":"2017","unstructured":"Deyab G, Hokstad I, Whist JE, Smastuen MC, Agewall S, Lyberg T, et al. Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis. Arthritis Res Ther. 2017;19(1):232.","journal-title":"Arthritis Res Ther"},{"key":"248_CR19","doi-asserted-by":"crossref","unstructured":"Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I et al. PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. PLoS Med [Internet]. 2013;10(4). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3621753\/","DOI":"10.1371\/journal.pmed.1001419"},{"issue":"5","key":"248_CR20","doi-asserted-by":"publisher","first-page":"e0126347","DOI":"10.1371\/journal.pone.0126347","volume":"10","author":"W-C Tsai","year":"2015","unstructured":"Tsai W-C, Ou T-T, Yen J-H, Wu C-C, Tung Y-C. Long-term frequent use of non-steroidal anti-inflammatory drugs might protect patients with ankylosing spondylitis from cardiovascular diseases: a nationwide case-control study. PLoS ONE. 2015;10(5):e0126347.","journal-title":"PLoS ONE"},{"issue":"36","key":"248_CR21","doi-asserted-by":"publisher","first-page":"e4792","DOI":"10.1097\/MD.0000000000004792","volume":"95","author":"L-C Wu","year":"2016","unstructured":"Wu L-C, Leong P-Y, Yeo K-J, Li T-Y, Wang Y-H, Chiou J-Y, et al. Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: a nation-wide, population-based case-control study. Medicine (Baltimore). 2016;95(36):e4792.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"248_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/annrheumdis-2014-206147","volume":"75","author":"I Essers","year":"2016","unstructured":"Essers I, Stolwijk C, Boonen A, De Bruin ML, Bazelier MT, de Vries F, et al. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis. 2016;75(1):203\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"248_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13075-018-1669-x","volume":"20","author":"JL Lee","year":"2018","unstructured":"Lee JL, Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study. Arthritis Res Ther. 2018;20(1):171.","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 2","key":"248_CR24","first-page":"336","volume":"76","author":"E Rivi\u00e8re","year":"2017","unstructured":"Rivi\u00e8re E, Etcheto A, den Bosch FV, der Heijde DV, Landew\u00e9 R, Dougados M, et al. THU0350 Effect of NSAID consumption on cardiovascular events in spondyloarthritis. Ann Rheum Dis. 2017;76(Suppl 2):336\u2013336.","journal-title":"Ann Rheum Dis"},{"key":"248_CR25","unstructured":"Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. https:\/\/handbook-5-1.cochrane.org\/front_page.htm."},{"key":"248_CR26","unstructured":"Ottawa Hospital Research Institute [Internet]. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Cited 10 Mar 2019."},{"key":"248_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jclinepi.2018.05.021","volume":"101","author":"J-M Losilla","year":"2018","unstructured":"Losilla J-M, Oliveras I, Marin-Garcia JA, Vives J. Three risk of bias tools lead to opposite conclusions in observational research synthesis. J Clin Epidemiol. 2018;101:61\u201372.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"248_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.mayocp.2017.01.001","volume":"92","author":"MH Murad","year":"2017","unstructured":"Murad MH. Clinical practice guidelines: a primer on development and dissemination. Mayo Clin Proc. 2017;92(3):423\u201333.","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"248_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"19","key":"248_CR30","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF. What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690\u20131.","journal-title":"JAMA"},{"issue":"4","key":"248_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the e-value. Ann Intern Med. 2017;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"issue":"8","key":"248_CR32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/acr.22555","volume":"67","author":"LE Kristensen","year":"2015","unstructured":"Kristensen LE, Jakobsen AK, Askling J, Nilsson F, Jacobsson LTH. Safety of etoricoxib, celecoxib, and nonselective nonsteroidal antiinflammatory drugs in ankylosing spondylitis and other spondyloarthritis patients: a Swedish National Population-Based Cohort Study. Arthritis Care Res. 2015;67(8):1137\u201349.","journal-title":"Arthritis Care Res"},{"issue":"3","key":"248_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"key":"248_CR34","unstructured":"Myocardial Infarctions Among Ankylosing Spondylitis Patients in a Large US Insurance Database [Internet]. ACR Meeting Abstracts. Available from: https:\/\/acrabstracts.org\/abstract\/myocardial-infarctions-among-ankylosing-spondylitis-patients-in-a-large-us-insurance-database\/. Cited 25 Aug 2019."},{"issue":"Suppl 2","key":"248_CR35","first-page":"1000","volume":"77","author":"A Deodhar","year":"2018","unstructured":"Deodhar A, Winthrop KL, Bohn RL, Chan BK, Suruki RY, Stark JL, et al. SAT0272 Do TNF inhibitors impact the comorbidities and extra-articular manifestations, and thereby alter the natural history of ankylosing spondylitis? Ann Rheum Dis. 2018;77(Suppl 2):1000\u20131000.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"248_CR36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10067-018-4037-y","volume":"37","author":"M Vinker Shuster","year":"2018","unstructured":"Vinker Shuster M, Gendelman O, Tiosano S, Comaneshter D, Cohen AD, Amital H. Ischemic heart disease and ankylosing spondylitis\u2014assessing the role of inflammation. Clin Rheumatol. 2018;37(4):1053\u20138.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"248_CR37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/ard.2007.076760","volume":"68","author":"NJ Goodson","year":"2009","unstructured":"Goodson NJ, Brookhart AM, Symmons DPM, Silman AJ, Solomon DH. Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care-based inception cohort of patients. Ann Rheum Dis. 2009;68(3):367\u201372.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"248_CR38","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1136\/annrheumdis-2012-203137","volume":"73","author":"J Lindhardsen","year":"2014","unstructured":"Lindhardsen J, Gislason GH, Jacobsen S, Ahlehoff O, Olsen AMS, Madsen OR, et al. Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. Ann Rheum Dis. 2014;73(8):1515\u201321.","journal-title":"Ann Rheum Dis."},{"key":"248_CR39","unstructured":"Research C for DE and. Vioxx (rofecoxib) Questions and Answers. FDA [Internet]. 2018 Nov 3; Available from: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/vioxx-rofecoxib-questions-and-answers. Cited 21 Aug 2019."},{"key":"248_CR40","first-page":"148","volume":"77","author":"L Gensler","year":"2018","unstructured":"Gensler L, Gianfrancesco M, Weisman M, et al. OP0198 Combined effects of tumour necrosis factor inhibitors and nsaids on radiographic progression in ankylosing spondylitis. Ann Rheum Dis. 2018;77:148.","journal-title":"Ann Rheum Dis"},{"issue":"270","key":"248_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijcard.2018.06.099","volume":"1","author":"NAB Ntusi","year":"2018","unstructured":"Ntusi NAB, Francis JM, Sever E, Liu A, Piechnik SK, Ferreira VM, et al. Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases. Int J Cardiol. 2018;1(270):253\u20139.","journal-title":"Int J Cardiol"},{"issue":"7","key":"248_CR42","doi-asserted-by":"publisher","first-page":"e0220079","DOI":"10.1371\/journal.pone.0220079","volume":"14","author":"I Hokstad","year":"2019","unstructured":"Hokstad I, Deyab G, Wang Fagerland M, Lyberg T, Hjeltnes G, F\u00f8rre \u00d8, et al. Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study. PLoS ONE. 2019;14(7):e0220079.","journal-title":"PLoS ONE"},{"issue":"1","key":"248_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13075-019-1882-2","volume":"21","author":"A Deodhar","year":"2019","unstructured":"Deodhar A, Mease PJ, McInnes IB, Baraliakos X, Reich K, Blauvelt A, et al. Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data. Arthritis Res Ther. 2019;21(1):111.","journal-title":"Arthritis Res Ther."}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-020-00248-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40744-020-00248-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-020-00248-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T12:51:25Z","timestamp":1608036685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40744-020-00248-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1007\/s40744-020-00248-x","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"assertion":[{"value":"16 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}